The Department of Pharmacology, Siddaganga Medical College & Research Institute (SMCRI), Tumakuru, was recognized as an Adverse Drug Reactions Monitoring Centre (AMC) under PvPI on 28 April 2023.
Since its recognition, the department has reported more than 200 ADR cases through VigiFlow up to September 2026.
The department celebrated National Pharmacovigilance Week from 17–23 September 2026 through a series of educational and awareness activities.
The inaugural programme featured a guest lecture by Dr. Raghav M V on ADR reporting through the VigiFlow online platform, followed by the release of the Pharmacovigilance Newsletter. Faculty members sensitized patients, patient attenders, and the general public on the role of pharmacovigilance in ensuring safe, effective, and appropriate use of medicines.
Students participated enthusiastically in face painting, poster presentation, Rangoli, and quiz competitions focusing on ADRs, drug safety, medication errors, ADR reporting, rational use of medicines, and pharmacovigilance.
Dr. Jayanthi MK, Professor of Pharmacology, Shridevi Institute of Medical Sciences & Research Hospital, Tumakuru, addressed postgraduate students on early identification and reporting of ADRs.
Dr. Dharmaraj B, Professor of Pharmacology, SMCRI, addressed students on Materiovigilance and the Materiovigilance Programme of India (MVPI).
The department extended awareness to the wider community through social media platforms and released its annual Pharmacovigilance Newsletter.
The Quiz Competition enhanced students’ knowledge and awareness regarding pharmacovigilance, ADRs, and medication safety. Prizes were distributed to the winners, recognizing their active participation, creativity, knowledge, and contribution towards promoting pharmacovigilance awareness.
The week concluded as a meaningful initiative reinforcing the department’s commitment to medicine safety, ADR reporting, rational use of medicines, and patient safety.
